# Presentation: 717984

## 		     National Cancer InstituteDivision of Cancer Control & Population Sciences

** ****s****BIR****/STTR eHEALTH   ****FUNDING FOR SMALL**
**   ****BUSINESSES AND NON-PROFITS**

##        PROGRAM OBJECTIVES

- -	**Translate basic cancer science and research into prevention and control applications for medical and community settings.**
**-****	****Use *****innovative a*****pproaches and media technology to develop research-based programs, interventions, systems, networks, or products needed by the public or primary care professionals to reduce cancer risk or improve the quality of life of cancer survivors.**

## HOW DO WE DO THIS?

**HOW DO WE DO THIS?**

**    **
**    **
**    ****Two grant mechanisms are used to translate science into**
**    ****commercial applications:   **
**    ****SBIR: R43/R44        Small Business Innovation **
**	****	****	****     ****Research Grants**
**    ****STTR: R41/42 ****	****     Small Business Technology Transfer **
**                        ****	****     ****Grants - for non-profits organizations **
**                                      ****collaborating with small businesses**
**   **
**    **

## HOW DO THESE TWO GRANTS DIFFER?

**HOW DO THESE TWO GRANTS DIFFER?**

**    **
**     ****SBIR: R43/R44 – Small Business****	****	****STTR: R41/42 – Non-Profit**
**     **
**     ****Research Control****	****	****	****	****Research Control**
**     ****Phase I; 6-12 months****	****	****	****Same**
**     ****Direct Costs: $100,000 ****	****	****	****Same**
**     ****Phase II: 2-3 years****	****	****	****	****Same**
**     ****Direct Costs: $750,000 ****	****	****	****Same **
**     ****Employed by company: 51% ****	****	****On non-profit staff; must**
**	****	****	****	****	****	****work with small business**
**     **
**     ****Must be U.S. citizen****	****	****	****	****Same**
**     ****Due:  April 1, August 1, December 1****	****Same**
**	**
**       **

##          TRADITIONAL OR FAST TRACK

**                ****Traditional****	****	****	****      Fast Track**
**Phase I submitted, reviewed;****	****Phase I & II submitted & reviewed at the**
**if funded, completed in  ****	****	****same time; if funded, given one score for**
**6-12 months****	****	****	****both phases; Phase I is 6-12 months**
**	****	****	****	****Reviewers have option to separate and fund ****	****	****	****	****Phase I only**
**Phase II submitted, completed****	****Duration of Phase II - same**
**In 2-4 years**
**Funding gap between****	****	****Funding gap – 2-3 weeks **
**Phase I & II -  18 months**
**Who applies? Generally, mid-size small businesses or individuals with  experience in research or technology development and grant writing**

##       WHAT NEEDS TO BE ACCOMPLISHED?

**      ****WHAT NEEDS TO BE ACCOMPLISHED?**
**	****>****	****Phase I: feasibility test or pilot study**
**>****	****Phase II: develops, implements, and tests the ****	**
**	****effectiveness of new or existing models of **
**	****behavior modification or informational/ **
**	****educational or training applications**

## 	New Requirements for eHealth 	      SBIR/STTR Applicants 

- To improve the potential for successful commercialization, all _**Phase II applicants must address**_:
- -	**organizational infrastructure issues – **Applicants** **must work with a “site** **administrator” to remove barriers to use
- -	**long-term tracking - **Applicants must build-in a tracking component to evaluate sales and product usage
- -	**usability - **Applicants must participant in usability testing at NCI’s Technology Lab in addition to their independent usability testing.

##               How are eHealth SBIR/STTR 

**              ****How are eHealth SBIR/STTR **
**	****    ****Research Categories Selected?**
**	**
**	**
**	**
**	****Categories result from:**
** ****	****S****	****Congressional Priorities for NCI**
**	****S****	****Senate Committee’s Report on NCI**
**	****S****	****NCI Director’s Budget Proposal for Cancer ****	****	****	****Research**
**	****S****	****Expressed opinions of the NCAB**
**	****S****	****Expressed needs of primary care providers, ****	****	****oncologists and the public**
**	**

##     EHEALTH RESEARCH CATEGORIES 

**Life Styles Associated with Cancer Risk ****(nutrition intakes/      habits, smoking habits, physical activity, sun screening habits)**
**Cancer Genetics ****(decisions-making)**
**Communication Techniques ****(****for specific cancers, hard to**
**          ****reach populations, physically challenged populations****)**
- -	**Innovative Alternative Teaching & Training Methods**
**Complementary Medicine Approaches **
**Survivorship and Quality of Life Issues ****(pain management)**
**Systems for Primary Care Professionals/Oncologists &**
**	****Systems for the Public ****(training, education, screening, **
**          ****assessment, treatment)**
- -	**Clinical Trials**

##   APPLICANT CHARACTERISTICS

**  ****APPLICANT CHARACTERISTICS**
**	****-****	****Research-oriented**
**	****-****	****Former University Faculty**
**	****-****	****Health Communication Experts**
**	****-****	****Media Technology Experts**
**	****-****	****MD, PhD, MPH, MA, MBA, BS, JD**
**	**

##   WHO ARE THE EHEALTH REVIEWERS?

_**Deans**_** of Public Health, Nursing, Medicine **
_**Professors**_** of nursing; medicine, oncology; behavior and preventive medicine; kinesiology; music therapy and other CAM topics; health communication; community health; psychology; business; health sciences and bio-communication; pediatrics and human development; surveys/data collection/statistics; education**
_**Researches**_** in social work, oncology, epidemiology & clinical applications**
_**Media Technology companies**_

## WHAT DO REVIEWERS EXPECT?

**WHAT DO REVIEWERS EXPECT?**

**Significance: to science field and NCI activities**
**Approach: theory and experience-based**** **
**Innovation: use of technology/approach to **
**         ****problem**
**Measurable outcomes**
**Qualified investigators and research team**
**Appropriate environment and equipment**
**Safeguards for human subjects**
**Realistic budget**
**Commercialization Potential**

##     REVIEW AND POTENTIAL FOR FUNDING 

**SBIR/STTR****	****      External Reviewers monitored by a****	****	****      Scientific Review Administrator, NIH**
**	****	****      ****Center for Scientific Review **
**Funding****	****      approximately 1/3 are funded**
**Potential**

##       $$FUNDING$$: AN NIH SET-A-SIDE

**      ****$$****FUNDING****$$: ****AN NIH SET-A-SIDE**
**     **_**% of Institute Budgets Set-aside for SBIR R&D**_
**	****FY 1997 and Beyond:  ****2.5 %****; **_**must be spent**_
**      **
**	****Pay lines:**
**	****-  determined by the Budget Office**
**	****-  based on the number of applications submitted**
**	****   ****and funded from previous year, special initiatives, and**
**	****   ****number of SBIR contracts**
**	****-  FY04 SBIR pay line: 220; STTR pay line: 205**

## Funding: Total NCI and eHealth* SBIR/STTR $$$ spent: 1987-2003 (Multimedia Technology HealthCommunication SBIR Program*; ** = does not include last cycle in 2003)

| FY | NCI Total $ | 
eHealth Portfolio |
| --- | --- | --- |
| 1987 |  $      204,000  |   |
| 1988 |  $      475,116  |   |
| 1989 |  $      215,257  |   |
| 1990 |  $   1,041,425  |   |
| 1991 |  $   1,312,389  |   |
| 1992 |  $   1,403,841  |   |
| 1993 |  $   2,826,196  |  $  1,005,329  |
| 1994 |  $   8,199,765  |  $     601,417  |
| 1995 |  $ 29,787,310  |  $  2,426,664  |
| 1996 |  $ 35,620,714  |  $  3,367,391  |
| 1997 |  $ 47,107,622  |  $  5,519,600  |
| 1998 |  $ 50,781,484  |  $  9,077,892  |
| 1999 |  $ 57,427,413  |  $10,274,040  |
| 2000 |  $ 65,902,460  |  $11,745,677  |
| 2001 |  $ 75,925,391  |  $  9,370,609  |
| 2002 |  $ 86,269,375  |  $  9,578,217  |
| 2003 |  $ 39,841,558  |  $  3,915,032  |
| Grand Total |  $504,341,316  |  $66,881,868  |

| Total NCI Awards | Total eHealth Awards* | eHealth % of Budget |
| --- | --- | --- |
| 1 |   | 0% |
| 2 |  | 0% |
| 2 |  | 0% |
| 7 |  | 0% |
| 8 |  | 0% |
| 10 |  | 0% |
| 19 | 4 | 21% |
| 58 | 6 | 10% |
| 168 | 15 | 9% |
| 183 | 19 | 10% |
| 256 | 28 | 11% |
| 259 | 45 | 17% |
| 311 | 39 | 13% |
| 316 | 46 | 15% |
| 336 | 37 | 11% |
| 381 | 34 | 9% |
| 171 | 14 | 8%** |
| 2488 | 287 | 12% |

## Linking Science with Business: NCI SBIR/STTR Product Showcases

**All Phase II grantees present their research findings and demo their product to the NIH community.**
**    •****	****Showcase I: 10/2-3, 2000; ****22**** products **
**    •****	****Showcase II: 9/6-7, 2001; ****13**** products **
**    •****	****Showcase III: 9/25-26, 2003; ****19**** products ****	**
**    •****	****Video casts: MTHC “Linking Science and Business” ****	****	****Series can be seen at: http://videocast.nih.gov ****(click past events ****	****under)**
**    •****	****Product information and grant synthesis is continuously ****	****being posted on Program homepage**

##       EVERY THING YOU NEED TO KNOW ABOUT 	 

**             ****SBIR/STTR GRANTS & CONTRACTS**

** ****	****Your NIH SBIR/STTR RESOURCE:**
**   ****	****http://www.nih.gov/grants/funding/sbir.htm**

##   Applicants and grantees may 

**Program Director do for you?**

**  ****Applicants and grantees may**** **
** ****	****Contact staff ANYTIME, preferably by email**
** ****	****Receive pre-application advice and guidance**
**   ****Receive post-review advice and guidance**
**   ****Receive post-award advice and guidance**

## For further information:

- 		Connie Dresser, RDPH, LN
- 		Acting NCI SBIR Liaison to the NIH OD
- 		Program Director, Multimedia Technology &
- 		Health Communication SBIR Grants
- 		Health Communication & Informatics Research Branch
- 		Behavioral Research Program
- 		Division of Cancer Control & Population Sciences
- 		National Cancer Institute
- 		6130 Executive Blvd, EPN - Rm. 4072
- 		Bethesda, MD  20892-7365
- 		301/435-2846
- 		301/480-2087 Fax
- 		cd34b@nih.gov
- 		**http://cancercontrol.cancer.gov/hcirb/sbir/**